Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000011

CEO bought 17,500 shares at $0.02 ($390)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-12 Purchase : show line 1 in the form +10,000 $0.02 $223 21,354,623 D
2019-02-12 Purchase : show line 2 in the form +2,500 $0.02 $56 21,357,123 D
2019-02-12 Purchase : show line 3 in the form +5,000 $0.02 $112 21,362,123 D
Open-market purchases · 17,500 sh · avg $0.02 · $390
Loading xslF345X03/primary_doc.xml…